Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.
Lopes N, Bergsland C, Bruun J, Bjørnslett M, Vieira AF, Mesquita P, Pinto R, Gomes R, Cavadas B, Bennett E, Pereira L, Lothe RA, Almeida R, David L. Lopes N, et al. Among authors: Bjornslett M. Gastric Cancer. 2020 Mar 25. doi: 10.1007/s10120-020-01064-6. Online ahead of print. Gastric Cancer. 2020. PMID: 32215766
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2.
Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J. Lopes N, et al. Among authors: Bjornslett M. Lab Invest. 2020 Jan;100(1):120-134. doi: 10.1038/s41374-019-0336-4. Epub 2019 Oct 22. Lab Invest. 2020. PMID: 31641225 Free PMC article.
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.
Lønning PE, Berge EO, Bjørnslett M, Minsaas L, Chrisanthar R, Høberg-Vetti H, Dulary C, Busato F, Bjørneklett S, Eriksen C, Kopperud R, Axcrona U, Davidson B, Bjørge L, Evans G, Howell A, Salvesen HB, Janszky I, Hveem K, Romundstad PR, Vatten LJ, Tost J, Dørum A, Knappskog S. Lønning PE, et al. Among authors: Bjornslett M. Ann Intern Med. 2018 Mar 6;168(5):326-334. doi: 10.7326/M17-0101. Epub 2018 Jan 16. Ann Intern Med. 2018. PMID: 29335712
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.
Landskron J, Kraggerud SM, Wik E, Dørum A, Bjørnslett M, Melum E, Helland Ø, Bjørge L, Lothe RA, Salvesen HB, Taskén K. Landskron J, et al. Among authors: Bjornslett M. PLoS One. 2017 Jul 31;12(7):e0182030. doi: 10.1371/journal.pone.0182030. eCollection 2017. PLoS One. 2017. PMID: 28759630 Free PMC article.
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, Bjørnslett M, Meza-Zepeda LA, Eknæs M, Lind GE, Myklebost O, Skotheim RI, Sveen A, Lothe RA. Berg KCG, et al. Among authors: Bjornslett M. Mol Cancer. 2017 Jul 6;16(1):116. doi: 10.1186/s12943-017-0691-y. Mol Cancer. 2017. PMID: 28683746 Free PMC article.
The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB, Bjørnslett M, Halle MK, Salvesen HB, Dørum A, Birkeland E, Hveem K, Romundstad P, Vatten L, Lønning PE, Knappskog S. Gansmo LB, et al. Among authors: Bjornslett M. Tumour Biol. 2016 Aug;37(8):10697-702. doi: 10.1007/s13277-016-4940-2. Epub 2016 Feb 11. Tumour Biol. 2016. PMID: 26867771 Free PMC article.
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.
Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E; Norwegian Breast Cancer Group trial NBCG VI, Tollenaar RA, Seynaeve C, Devilee P, Salvesen HB, Dørum A, Hveem K, Vatten L, Lønning PE. Knappskog S, et al. Among authors: Bjornslett M. PLoS One. 2012;7(4):e36263. doi: 10.1371/journal.pone.0036263. Epub 2012 Apr 30. PLoS One. 2012. PMID: 22558411 Free PMC article.
15 results
Jump to page